Company Filing History:
Years Active: 2019-2021
Title: Elena Kistanova: Innovator in Chimeric Clotting Factors
Introduction
Elena Kistanova is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of chimeric clotting factors. With a total of 2 patents, her work is paving the way for advancements in coagulation therapies.
Latest Patents
Kistanova's latest patents focus on chimeric clotting factors that comprise an activatable clotting factor and an enhancer moiety. The activatable clotting factor allows for activation at the site of coagulation, while the enhancer moiety improves the procoagulation activities of these factors. Additionally, these chimeric clotting factors can be enhanced by fusing them to a half-life extender, which improves their pharmacokinetic properties. The patents also include methods for making and using these innovative chimeric clotting factors.
Career Highlights
Elena Kistanova is currently associated with Bioverativ Therapeutics Inc., where she continues to push the boundaries of research in her field. Her work has garnered attention for its potential to improve treatment options for patients with coagulation disorders.
Collaborations
Kistanova collaborates with talented individuals such as Joe Salas and Vu Phong Hong, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Elena Kistanova's contributions to the field of biotechnology, particularly through her patents on chimeric clotting factors, highlight her role as a leading inventor. Her work not only advances scientific knowledge but also has the potential to significantly impact patient care in coagulation therapies.